Heart Attack Severity & Circadian Rhythm: New Link Uncovered
timing is Everything: Unlocking the Secrets of Heart Attack Severity and a New Era of Chronotherapy
Houston, TX – A groundbreaking study has illuminated the intricate molecular mechanisms behind why heart attacks are more severe when they strike in the morning, paving the way for novel, time-sensitive therapeutic strategies. Researchers have identified a critical interaction between two proteins, BMAL1 and HIF2A, as the linchpin regulating the heart’s response to injury and its ability to heal, offering a new viewpoint on chronotherapy for cardiovascular disease.
Previous research has consistently demonstrated a stark temporal disparity in heart attack outcomes, with morning attacks leading to more meaningful heart damage, increased instances of fatal arrhythmias and heart failure, and ultimately, worse prognoses. The underlying reasons for this phenomenon, however, have remained elusive until now.
“If you have a heart attack in the morning, you are more likely to have fatal arrhythmias, heart failure, and you’re more likely to die from it. the question we asked is ’Why?'” explained Holger Eltzschig, MD, PhD, senior author and chair and professor of the Department of Anesthesiology, Critical Care and Pain Medicine at mcgovern Medical School at UTHealth Houston.
The study, published in a leading scientific journal, pinpoints the interaction between BMAL1, a core circadian rhythm protein governing biological processes like sleep-wake cycles and metabolism, and HIF2A, a protein crucial for adapting to low oxygen conditions, as the key factor. Heart attacks, by their nature, involve a blockage of blood flow, leading to oxygen deprivation and subsequent heart muscle death. The researchers discovered that the interplay between BMAL1 and HIF2A dictates how heart cells respond to this critical lack of oxygen following a heart attack, thereby modulating the heart’s vulnerability to injury.
In preclinical models,the research team observed that heart attacks occurring around 3 a.m.resulted in substantially greater cardiac damage, characterized by larger infarct sizes and a heightened risk of heart failure. Conversely, heart attacks occurring at 3 p.m. were associated with less severe outcomes, with the heart demonstrating a superior capacity to adapt to low oxygen levels and initiate efficient healing processes.
Further inquiry revealed that BMAL1 and HIF2A collaboratively target a specific gene, amphiregulin (AREG). AREG plays a pivotal role in modulating the extent of heart damage throughout the day.crucially,the researchers found that by targeting this BMAL1 and HIF2A-AREG pathway with pharmacological interventions,they could confer significant protection to the heart,especially when treatments were administered in alignment with the body’s natural circadian rhythms.
“This discovery opens up new avenues for treating heart attacks by considering the timing of drug management,” stated Eltzschig, who also holds the John P. and Kathrine G. McGovern Distinguished University Chair at McGovern Medical School. “Our findings highlight the potential to use targeted drugs toward those proteins to reduce the severity of heart attacks when administered at specific times. similarly, patients undergoing cardiac surgery may benefit from such drugs, like the hypoxia-inducible factor activator vadadustat, when given before their operation.”
The research team, including Kuang-Lei Tsai, phd, and Tao Li, PhD, from the Department of Biochemistry and Molecular Biology at McGovern Medical School, utilized high-resolution cryo-electron microscopy to meticulously map the structural interactions between BMAL1 and HIF2A. This advanced imaging provided the first direct molecular evidence of their complex formation, offering critical insights that can guide the advancement of novel therapeutic strategies.
As Eltzschig emphasized, future clinical trials are essential to validate whether synchronizing treatments with the body’s internal clock can indeed enhance patient outcomes. This pioneering work not only demystifies the temporal variations in heart attack severity but also heralds a new era of chronotherapy, where the precise timing of medical interventions could dramatically improve the lives of cardiovascular patients.